Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome. (Q46853686)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2006

Language	Label	Description	Also known as
English	Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome.	scientific article published in February 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Chanel S

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Soignet S

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Pandolfi PP

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Guernah I

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Warrell R

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Nimer S

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

212-217

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16357841%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Epigenetics in human disease and prospects for epigenetic therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Chromatin modification, leukaemia and implications for therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Histone acetylation in chromatin structure and transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Gene silencing in cancer in association with promoter hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Long-term treatment of girls with ornithine transcarbamylase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in v

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

21 January 2018

A positive role for histone acetylation in transcription factor access to nucleosomal DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404050

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46853686&oldid=2208179575"